The lower expression levels of the TFs, EZH2, SUZ12 and higher expression of BACH1 and MTF2 were found to be significantly associated with better OS and prognosis in BC patients (Supplementary Fig. S1). This evidence concerns the gene EZH2 and breast cancer.